Advertisement

Sarcopenia in patients with malignant pleural effusion: impact on symptoms, health status, and response to hospitalization

  • Janet Rodríguez-Torres
  • Laura López-López
  • Irene Cabrera-Martos
  • Gerald Valenza-Demet
  • Lawrence P. Cahalin
  • Marie Carmen ValenzaEmail author
Original Article

Abstract

Background

Malignant pleural effusion (MPE) refers to the presence of neoplastic cells in the pleural fluid and was previously associated with lung cancer, breast cancer, and lymphoma. Patients with MPE effusion have significant symptoms, diminishing their overall quality of life but little is known about the influence sarcopenia may have on their clinical presentation.

Purpose

To examine the prevalence of sarcopenia in patients with MPE and its relationship with symptoms, health status, and the response to hospitalization.

Methods

Seventy-four patients with MPE underwent measurements of symptoms, health-related quality of life, and functional status upon admission, discharge, and 3 months after hospital discharge.

Results

Patients with MPE and sarcopenia were symptomatic during hospitalization and at discharge. Additionally, health-related quality of life and functional status were worse in patients with MPE and sarcopenia. All measures of patients with MPE and sarcopenia were significantly poorer 3 months after hospital discharge.

Conclusions

Sarcopenia is a clinical characteristic with substantial negative effects in patients with MPE. Specific interventions may need to be provided, designed, and offered in the clinical setting.

Keywords

Malignant pleural effusion Sarcopenia Hospitalization Symptoms 

Notes

Funding

The author JRT has received financial support through a FPU (“Formación Profesorado Universitario”) grant (FPU:16/01531) of the Spanish Ministry of Education.

The author LPP has received financial support through a FPU grant (FPU: 17/00408) of the Spanish Ministry of Education.

This research has also received financial support of the “Fundación Pública Andaluza para la Investigación Biosanitaria (FIBAO)”, through a project.

Compliance with ethical standards

All patients’ data are confidential.

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Maskell NA, Butland RJ, Pleural Diseases Group, Standards of Care Committee, British Thoracic Society (2003) BTS guidelines for the investigation of a unilateral pleural effusion in adults. Thorax 58:8–17CrossRefGoogle Scholar
  2. 2.
    Porcel JM, Light RW (2006) Diagnostic approach to pleural effusion in adults. Am Fam Physician 73(7):1211–1220Google Scholar
  3. 3.
    Karkhanis VS, Joshi JM (2012) Pleural effusion: diagnosis, treatment, and management. Open Access Emerg Med 22(4):31–52CrossRefGoogle Scholar
  4. 4.
    Porcel JM, Esquerda A, Vives M, Bielsa S (2014) Etiology of pleural effusions: analysis of more than 3,000 consecutive thoracenteses. Arch Bronconeumol 50(5):161–165CrossRefGoogle Scholar
  5. 5.
    Kastelik JA (2013) Management of malignant pleural effusion. Lung 191(2):165–175CrossRefGoogle Scholar
  6. 6.
    Roberts ME, Neville E, Berrisford RG, Antunes G, Ali NJ, BTS Pleural Disease Guideline Group (2010) Management of a malignant pleural effusion: British Thoracic Society pleural disease guideline. Thorax 65:32–40CrossRefGoogle Scholar
  7. 7.
    Kookoolis AS, Puchalski JT, Murphy TE, Araujo KL, Pisani MA (2014) Mortality of hospitalized patients with pleural effusions. J Pulm Respir Med 4(3):184Google Scholar
  8. 8.
    MacEachern P, Tremblay A (2011) Pleural controversy: pleurodesis versus indwelling pleural catheters for malignant effusions. Respirology 16(5):747–754CrossRefGoogle Scholar
  9. 9.
    Egan AM, McPhillips D, Sarkar S, Breen DP (2014) Malignant pleural effusion. QJM 107(3):179–184CrossRefGoogle Scholar
  10. 10.
    Chernow B, Sahn SA (1997) Carcinomatous involvement of the pleura: an analysis of 96 patients. Am J Med 63(5):695–702CrossRefGoogle Scholar
  11. 11.
    Antony VB, Loddenkemper R, Astoul P, Boutin C, Goldstraw P, Hott J, Rodriguez-Panadero F, Sahn SA (2001) Management of malignant pleural effusions. Eur Respir J 18:402–419CrossRefGoogle Scholar
  12. 12.
    Ekpe EE, Ikpe M, IN U (2013) Palliative treatment of malignant pleural effusion. Diag Ther Stud 2(1):8–20Google Scholar
  13. 13.
    Kalyani RR, Corriere M, Ferrucci L (2014) Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases. Lancet Diabetes Endocrinol 2(10):819–829CrossRefGoogle Scholar
  14. 14.
    Jones SE, Maddocks M, Kon SS, Canavan JL, Nolan CM, Clark AL, Polkey MI, Man WD (2015) Sarcopenia in COPD: prevalence, clinical correlates and response to pulmonary rehabilitation. Thorax 70(3):213–218CrossRefGoogle Scholar
  15. 15.
    Cerri AP, Bellelli G, Mazzone A, Pittella F, Landi F, Zambon A, Annoni G (2015) Sarcopenia and malnutrition in acutely ill hospitalized elderly: prevalence and outcomes. Clin Nutr 34(4):745–751CrossRefGoogle Scholar
  16. 16.
    Morley JE, Anker SD, von Haehling S (2014) Prevalence, incidence, and clinical impact of sarcopenia: facts, numbers, and epidemiology-update. J Cachexia Sarcopenia Muscle 5(4):253–259CrossRefGoogle Scholar
  17. 17.
    Guinan EM, Doyle SL, Bennett AE, O’Neill L, Gannon J, Elliott JA, O’Sullivan J, Reynolds JV, Hussey J (2018) Sarcopenia during neoadjuvant therapy for oesophageal cancer: characterising the impact on muscle strength and physical performance. Support Care Cancer 26(5):1569–1576Google Scholar
  18. 18.
    Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383CrossRefGoogle Scholar
  19. 19.
    Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F et al (2010) Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people. Age Ageing 39(4):412–423CrossRefGoogle Scholar
  20. 20.
    Rolland Y, Lauwers-Cances V, Cournot M, Nourhashémi F, Reynish W, Rivière D et al (2003) Sarcopenia, calf circumference, and physical function of elderly women: a cross-sectional study. J Am Geriatr Soc 51(8):1120–1114CrossRefGoogle Scholar
  21. 21.
    Meek PM, Banzett R, Parsall MB, Gracely RH, Schwartzstein RM, Lansing R (2012) Reliability and validity of the multidimensional dyspnea profile. Chest 141(6):1546–1553CrossRefGoogle Scholar
  22. 22.
    Boonstra AM, Schiphorst Preuper HR, Reneman MF, Posthumus JB, Stewart RE (2008) Reliability and validity of the visual analogue scale for disability in patients with chronic musculoskeletal pain. Int J Rehabil Res 31(2):165–169CrossRefGoogle Scholar
  23. 23.
    Lee JS, Hobden E, Stiell IG, Wells GA (2003) Clinically important change in the visual analog scale after adequate pain control. Acad Emerg Med 10(10):1128–1130CrossRefGoogle Scholar
  24. 24.
    Birring SS, Prudon B, Carr AJ, Singh SJ, Morgan MD, Pavord ID (2003) Development of a symptom specific health status measure for patients with chronic cough: Leicester cough questionnaire (LCQ). Thorax 58(4):339–343CrossRefGoogle Scholar
  25. 25.
    Munoz G, Buxó M, de Gracia J, Olveira C, Martinez-Garcia MA, Giron R et al (2016) Validation of a Spanish version of the Leicester cough questionnaire in non-cystic fibrosis bronchiectasis. Chron Respir Dis 13(2):128–136CrossRefGoogle Scholar
  26. 26.
    Pornsuriyasak P, Thungtitigul P, Kawamatawong T, Birring SS, Pongmesa T (2017) Minimal clinically important differences (MCIDs) of the Thai version of the Leicester cough questionnaire for subacute and chronic cough. Value Health Reg Issues 12:57–62CrossRefGoogle Scholar
  27. 27.
    Pouchot J, Kherani RB, Brant R, Lacaille D, Lehman AJ, Ensworth S et al (2008) Determination of the minimal clinically important difference for seven fatigue measures in rheumatoid arthritis. J Clin Epidemiol 61(7):705–713CrossRefGoogle Scholar
  28. 28.
    Bernal-Vargas L, Riveros-Munévar F, Vinaccia-Alpi S, Quiceno-Sierra JM (2017) Estructura factorial y consistencia interna de la Escala de severidad de fatiga en población colombiana con enfermedades crónicas. Enfermería Global 16(46):37–49CrossRefGoogle Scholar
  29. 29.
    Badia X, Roset M, Montserrat S, Herdman M, Segura A (1999) The Spanish version of EuroQol: a description and its applications. European Quality of Life scale. Med Clin 112:79–85Google Scholar
  30. 30.
    Pickard AS, Neary MP, Cella D (2007) Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer. Health Qual Life Outcomes 5(1):70CrossRefGoogle Scholar
  31. 31.
    Paolinelli C, González P, Doniez ME, Donoso T, Salinas V (2001) Instrumento de evaluación funcional de la discapacidad en rehabilitación.: Estudio de confiabilidad y experiencia clínica con el uso del Functional Independence Measure. Rev Med Chile 129(1):23–31CrossRefGoogle Scholar
  32. 32.
    Hamilton BB, Laughlin JA, Fiedler RC, Granger CV (1994) Interrater reliability of the 7-level functional Independence measure (FIM). Scan J Rehabil Med 26(3):115–119Google Scholar
  33. 33.
    Beninato M, Gill-Body KM, Salles S, Stark P, Black-Schaffer RM et al (2006) Determination of the minimal clinically important difference in the FIM instrument in patients with stroke. Arch Phys Med Rehabil 87:32–39CrossRefGoogle Scholar
  34. 34.
    Valenza-Demet G, Valenza MC, Cabrera-Martos I, Torres-Sánchez I, Revelles-Moyano F (2014) The effects of a physiotherapy programme on patients with a pleural effusion: a randomized controlled trial. Clin Rehabil 28(11):1087–1095CrossRefGoogle Scholar
  35. 35.
    Phillips I, Tenny J, Gunn L, Nimako K, Hug A, Allan L, Ezhil V (2016) Sarcopenia in lung cancer. Eur J Surg Oncol 42(11):238CrossRefGoogle Scholar
  36. 36.
    Gariballa S, Alessa A (2013) Sarcopenia: prevalence and prognostic significance in hospitalized patients. Clin Nutr 32(5):772–776CrossRefGoogle Scholar
  37. 37.
    Hanai T, Shiraki M, Nishimura K, Ohnishi S, Imai K, Suetsugu A et al (2015) Sarcopenia impairs prognosis of patients with liver cirrhosis. Nutrition 31(1):193–199CrossRefGoogle Scholar
  38. 38.
    Narumi T, Watanabe T, Kadowaki S, Takahashi T, Yokoyama M, Kinoshita D et al (2015) Sarcopenia evaluated by fat-free mass index is an important prognostic factor in patients with chronic heart failure. Eur J Intern Med 26(2):118–122CrossRefGoogle Scholar
  39. 39.
    Prado CM, Lieffers JR, Bowthorpe L, Baracos VE, Mourtzakis M, McCargar LJ (2013) Sarcopenia and physical function in overweight patients with advanced cancer. Can J Diet Pract Res 74(2):69–74CrossRefGoogle Scholar
  40. 40.
    Kilgour RD, Vigano A, Trutschnigg B, Hornby L, Lucar E, Bacon SL, Morais JA (2010) Cancer-related fatigue: the impact of skeletal muscle mass and strength in patients with advanced cancer. J Cachexia Sarcopenia Muscle 1(2):177–185CrossRefGoogle Scholar
  41. 41.
    Go SW, Cha YH, Lee JA, Park HS (2013) Association between sarcopenia, bone density, and health-related quality of life in Korean men. Korean J Fam Med 34(4):281–288CrossRefGoogle Scholar
  42. 42.
    Landi F, Onder G, Russo A, Liperoti R, Tosato M, Martone AM, Capoluongo E, Bernabei R (2014) Calf circumference, frailty and physical performance among older adults living in the community. Clin Nutr 33(3):539–544CrossRefGoogle Scholar
  43. 43.
    Kasapoglu US, Arınç S, Gungor S, Irmak I, Guney P, Aksoy F et al (2016) Prognostic factors affecting survival in non-small cell lung carcinoma patients with malignant pleural effusions. Clin Respir J 10(6):791–799CrossRefGoogle Scholar
  44. 44.
    Lang T, Streeper T, Cawthon P, Baldwin K, Taaffe DR, Harris TB (2010) Sarcopenia: etiology, clinical consequences, intervention, and assessment. Osteoporos Int 21(4):543–559CrossRefGoogle Scholar
  45. 45.
    Denison HJ, Cooper C, Sayer AA, Robinson SM (2015) Prevention and optimal management of sarcopenia: a review of combined exercise and nutrition interventions to improve muscle outcomes in older people. Clin Interv Aging 10:859Google Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Physiotherapy, Faculty of Health SciencesUniversity of GranadaGranadaSpain
  2. 2.University of MiamiCoral GablesUSA

Personalised recommendations